Medical Isotopes, Inc.

Medical Isotopes, Inc. provides stable isotope chemicals and research compounds worldwide to universities, laboratories, hospitals, and government agencies. Established in 1985 by company founder Eric Stohler, Medical Isotopes produces a wide range of compounds labeled with Deuterium, N15, C13, O18 and metal isotopes. Among medical applications, the firm supplies Oxygen-18 water 98% and 10% to the medical community for Positron Emission Tomography (PET) and metabolic studies. Medical Isotopes, Inc. also supplies a unique product line of labeled and unlabeled vitamins for medical research, and specializes in multi-step custom syntheses for pharmaceutical companies, government, research facilities and hospitals. Medical Isotopes, Inc. provides products that are respected throughout the scientific community worldwide, are routinely cited in a variety of research publications, and are successfully employed in a broad range of medical applications across the globe. In addition to its expertise in synthesizing custom compounds as needed, Medical Isotopes’ inventory of over 33,000 products is one of the most complete offerings available anywhere. Predecessor Firms: Stohler Isotope Chemicals, Inc., the foundation for Medical Isotopes, Inc. was established by Eric Stohler in 1963 in Canada and relocated to Waltham, MA in 1969. The major product line was the production of NMR solvents and NMR supplies. Additionally, amino acids, fatty acids, sugars, steroids, labeled with Deuterium, C13, N15, and O18 were synthesized. The company was sold in 1984 to ICN, an international pharmaceutical company. Biodesign International, an antibody company based in Kennebunkport, Maine, was established in 1985 by Eric Stohler. The major product line was production of antibodies that were used in antibody kits for blood analysis in hospitals. Biodesign was sold in 1996 to a German international pharmaceutical company, Fresenius A.G.